Postoperative radiotherapy for prostate cancer: Evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy)

Strahlentherapie und Onkologie

Volumn 183, Issue 1, 2007, Pages 23-29

  Pinkawa, Michael ^b   Siluschek, Jaroslav ^c   Gagel, Bernd ^c   Piroth, Marc D ^c   Demirel, Cengiz ^c   Asadpour, Branka ^c   Eble, Michael J ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c NONE

Author keywords

Organ motion; Postoperative radiotherapy; Prostate cancer; Treatment planning

Indexed keywords

ARTICLE; BLADDER; BLADDER CAPACITY; BLADDER FILLING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; POSTOPERATIVE CARE; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RECTUM; RISK; SUPINE POSITION; TREATMENT PLANNING;

ARTIFACTS; HUMANS; MALE; MOVEMENT; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 33846447418     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1588-2     Document Type: Article

References (30)

1. Bastasch MD, Teh BS, Mal WY, et al. Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function. Int J Radiat Oncol Biol Phys 2002;54:101-6.
2. Bolla M, Van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005;366:572-8.
3. Cavey ML, Bayouth JE, Colman M, et al. IMRT to escalate the dose to the prostate while treating the pelvic nodes. Strahlenther Onkol 2005; 181:431-41.
4. Fiorino C, Foppiano F, Franzone P, et al. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. Radiother Oncol 2005; 74:187-95.
5. Galalae RM, Martinez A, Nuernberg N, et al. Hypofractionated conformal HDR brachytherapy in hormone-naive men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic groups? Strahlenther Onkol 2006;182:135-41.
6. Hille A, Christiansen H, Pradier O, et al. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 2005; 181:606-14.
7. Hille A, Schmidberger H, Tows N, et al. The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysis. Strahlenther Onkol 2005;181:709-16.
8. Höcht S, Wiegel T, Bottke D, et al. Computed tomogram prior to prostatectomy. Advantage in defining planning target volumes for postoperative adjuvant radiotherapy in patients with stage C prostate cancer. Strahlenther Onkol 2002;178:134-8.
9. ICRU. ICRU Report 50: Prescribing, recording and reporting photon beam therapy. Bethesda, MD, USA: International Commission on Radiation Units and Measurements, 1993.
10. Lee CT, Dong L, Ahamad AW, et al. Comparison of treatment volumes and techniques in prostate cancer radiation therapy. Am J Clin Oncol 2005; 28:618-25.
11. McLaughlin PW, Wygoda A, Sahijdak W, et al. The effect of patient position and treatment technique in conformal treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1999;45:407-13.
12. Meerleer GO, Vakaet L, Gersem W, et al. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 2000;47:639-48.
13. Miralbell R, Ozsoy O, Pugliesi A, et al. Dosimetric implications of changes in patient repositioning and organ motion in conformal radiotherapy for prostate cancer. Radiother Oncol 2003;66:197-202.
14. Mock U, Bogner J, Georg D, et al. Comparative treatment planning on localized prostate carcinoma. Conformai photon- versus proton-based radiotherapy. Strahlenther Onkol 2005;181:448-55.
15. Paddick I. A simple scoring ratio to index the conformity of radiosurgical plans. J Neurosurg 2000;93:Suppl 3:219-22.
16. Parker C, Warde P, Catton C. Salvage radiotherapy for PSA failure after radical prostatectomy. Radiother Oncol 2001;61:107-16.
17. Pinkawa M, Asadpour B, Gagel B, et al. Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder. Int J Radiat Oncol Biol Phys 2006;64:856-61.
18. Pinkawa M, Fischedick K, Asadpour B, et al. Low-grade toxicity after conformal radiation therapy for prostate cancer - impact of bladder volume. Int J Radiat Oncol Biol Phys 2006;64:835-41.
19. Sanguineti G, Castellone P, Foppiano F, et al. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder. Strahlenther Onkol 2004; 180:563-72.
20. Schwarz R, Krull A, Tribius S, et al. Results of three dimensional conformal radiotherapy and hormonal therapy for local recurrence after radical prostatectomy. Strahlenther Onkol 2005;181:442-7.
21. Swanson GP, Thompson IM, Tangen C, et al. Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SW0G 8794). Int J Radiat Oncol Biol Phys 2005;63 (Suppl 1):S1.
22. Teh BS, Bastasch MD, Wheeler TM, et al. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease. Int J Radiat Oncol Biol Phys 2003;56:184-91.
23. Teh BS, Mai WY, Augspurger ME, et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:465-72.
24. Tomé WA, Meeks SL, Buatti JM, et al. A high-precision system for conformal intracranial radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1137-43.
25. Wachter S, Gerstner N, Dorner D, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:91-100.
26. Weber DC, Nouet P, Rouzaud M, et al. Patient positioning in prostate radiotherapy: is prone better than supine? Int J Radiat Oncol Biol Phys 2000; 47:365-71.
27. Wiegel T, Miller K, Bottke D, et al. Adjuvante Strahlentherapie vs. "wait and see" beim pT3-Prostata-Ca. nach RP: Ergebnise einer Phase-III-Studie (ARO 96-02/AUO AP 09/95). Strahlenther Onkol 2005;181:3.
28. Zelefsky MJ, Aschkenasy E, Kelsen S, et al. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1997;39:327-33.
29. Zelefsky MJ, Crean D, Mageras GS, et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 1999;50:225-34.
30. Zellars RC, Roberson PL, Strawderman M, et al. Prostate position late in the course of external beam therapy: patterns and predictors. Int J Radiat Oncol Biol Phys 2000;47:655-60.